Introduction
The REB reviews clinical, epidemiological and behavioural adult oncology research projects, including basic science projects that use human materials. All research at the BC Cancer Agency involving humans or material and information derived from humans must be reviewed and approved by the REB before the project can be activated.
The REB is comprised of members who among them pool extensive experience and knowledge in scientific investigations, cancer research, the experience of cancer patients and the ethical issues raised by research involving humans.
The REB was implemented May 27, 2003.
-
Chair:
Dr. Ken Swenerton
-
Vice-Chair: Dr. Vivien Bramwell
Dr Swenerton and Dr Bramwell commenced in their roles on March 31, 2014.
History of Changes.2016May3.pdf
-
List 57: May 3, 2016.pdf
-
List 56: March 16, 2016.pdf
-
List 55: Aug 10, 2015
-
List 54: Feb 1, 2015
-
List 53: Sept 15, 2014
-
List 52: May 1, 2014
-
List 51: Mar 31, 2014
-
List 50: Feb 1, 2014
-
List 49: Jan 28, 2014
-
List 48: Jan 1, 2014
Membership in the REB is an interesting and exciting opportunity to contribute to the protection of human subjects in research.
All research ethics boards must consist of both male and female members with a variety of qualifications in order to provide a balanced perspective and to adhere to regulations that govern the Board.
If you are interested in becoming a member, send us a brief email telling us about yourself and why you are interested in becoming a member. It is helpful to attach your resume or CV in either a Word or PDF format.
Your interest is appreciated and all serious inquiries will be acknowledged.
The REB has produced annual reports since inception in May 2003.
The REB previously prepared annual reports based on the calendar year (Jan – Dec) up to and including 2006.
Annual reports from 2007 onward will be based on the fiscal year (April 1 – March 31).
